260 related articles for article (PubMed ID: 15756028)
1. Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin A on targeting ability and antitumor effect in vitro and in vivo.
Shiokawa T; Hattori Y; Kawano K; Ohguchi Y; Kawakami H; Toma K; Maitani Y
Clin Cancer Res; 2005 Mar; 11(5):2018-25. PubMed ID: 15756028
[TBL] [Abstract][Full Text] [Related]
2. Selective delivery of folate-PEG-linked, nanoemulsion-loaded aclacinomycin A to KB nasopharyngeal cells and xenograft: effect of chain length and amount of folate-PEG linker.
Ohguchi Y; Kawano K; Hattori Y; Maitani Y
J Drug Target; 2008 Nov; 16(9):660-7. PubMed ID: 18982514
[TBL] [Abstract][Full Text] [Related]
3. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice.
Yamada A; Taniguchi Y; Kawano K; Honda T; Hattori Y; Maitani Y
Clin Cancer Res; 2008 Dec; 14(24):8161-8. PubMed ID: 19088031
[TBL] [Abstract][Full Text] [Related]
4. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Mandelbaum-Shavit F; Qazen MM; Zalipsky S
Bioconjug Chem; 1999; 10(2):289-98. PubMed ID: 10077479
[TBL] [Abstract][Full Text] [Related]
5. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
[TBL] [Abstract][Full Text] [Related]
6. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
[TBL] [Abstract][Full Text] [Related]
7. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
[TBL] [Abstract][Full Text] [Related]
8. Folate-tethered emulsion for the target delivery of retinoids to cancer cells.
Kim SH; Kim JK; Lim SJ; Park JS; Lee MK; Kim CK
Eur J Pharm Biopharm; 2008 Mar; 68(3):618-25. PubMed ID: 17949957
[TBL] [Abstract][Full Text] [Related]
9. Relevance of folic acid/polymer ratio in targeted PEG-epirubicin conjugates.
Canal F; Vicent MJ; Pasut G; Schiavon O
J Control Release; 2010 Sep; 146(3):388-99. PubMed ID: 20621587
[TBL] [Abstract][Full Text] [Related]
10. 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitro.
Han X; Liu J; Liu M; Xie C; Zhan C; Gu B; Liu Y; Feng L; Lu W
Int J Pharm; 2009 May; 372(1-2):125-31. PubMed ID: 19166923
[TBL] [Abstract][Full Text] [Related]
11. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
Leamon CP; Cooper SR; Hardee GE
Bioconjug Chem; 2003; 14(4):738-47. PubMed ID: 12862426
[TBL] [Abstract][Full Text] [Related]
12. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
Chiu SJ; Marcucci G; Lee RJ
Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of diethylenetriamine pentaacetic acid-polyethylene glycol-folate: a new folate-derived, (99m)Tc-based radiopharmaceutical.
Liu M; Xu W; Xu LJ; Zhong GR; Chen SL; Lu WY
Bioconjug Chem; 2005; 16(5):1126-32. PubMed ID: 16173789
[TBL] [Abstract][Full Text] [Related]
14. A folate receptor-targeted emulsion formulation for paclitaxel.
Stevens PJ; Lee RJ
Anticancer Res; 2003; 23(6C):4927-31. PubMed ID: 14981947
[TBL] [Abstract][Full Text] [Related]
15. Receptor-mediated gene delivery by folate-PEG-baculovirus in vitro.
Kim YK; Choi JY; Yoo MK; Jiang HL; Arote R; Je YH; Cho MH; Cho CS
J Biotechnol; 2007 Sep; 131(3):353-61. PubMed ID: 17727999
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy.
Shukla S; Wu G; Chatterjee M; Yang W; Sekido M; Diop LA; Müller R; Sudimack JJ; Lee RJ; Barth RF; Tjarks W
Bioconjug Chem; 2003; 14(1):158-67. PubMed ID: 12526705
[TBL] [Abstract][Full Text] [Related]
17. Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate.
Salmaso S; Semenzato A; Caliceti P; Hoebeke J; Sonvico F; Dubernet C; Couvreur P
Bioconjug Chem; 2004; 15(5):997-1004. PubMed ID: 15366952
[TBL] [Abstract][Full Text] [Related]
18. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects and pharmacokinetics of aclacinomycin A carried by injectable emulsions composed of vitamin E, cholesterol, and PEG-lipid.
Wang J; Maitani Y; Takayama K
J Pharm Sci; 2002 Apr; 91(4):1128-34. PubMed ID: 11948551
[TBL] [Abstract][Full Text] [Related]
20. Induction of cancer cell-specific apoptosis by folate-labeled cationic liposomes.
Yoshida T; Oide N; Sakamoto T; Yotsumoto S; Negishi Y; Tsuchiya S; Aramaki Y
J Control Release; 2006 Apr; 111(3):325-32. PubMed ID: 16478640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
